World Health Organization To Include Dexamethasone In Updated COVID-19 Care Guidelines; Drops Hydroxychloroquine From Massive Solidarity Trial 17/06/2020 Grace Ren A rising star in the COVID-19 treatment arena, dexamethasone – a powerful corticosteroid – has stirred excitement among World Health Organization experts and researchers around the world, following the publication of promising early results from the United Kingdom’s Recovery trial. In COVID-19 patients only receiving supplemental oxygen, the trial found that dexamethasone reduced mortality by […] Continue reading -> United Kingdom Pauses Massive Hydroxychloroquine Trial After Finding “No Benefit” For COVID-19 Patients; The Lancet Retracts Hydroxychloroquine Paper 04/06/2020 Grace Ren In a series of flip-flops on Friday, the United Kingdom suspended the enrollment of new patients into the hydroxychloroquine arm of its massive RECOVERY trial, one of the largest randomised COVID-19 clinical trials in the world, after preliminary data showed “no benefit” for COVID-19 patients receiving the drug. The suspension of the trial came just […] Continue reading -> Gavi, The Vaccine Alliance Receives Big Private Industry Funding Commitments – Ahead Of Pledging Summit 03/06/2020 Elaine Ruth Fletcher & Grace Ren A day ahead of a major pledging event, Gavi-the Vaccine Alliance has received some US $70 million in pledges from a broad range of corporations, foundations, initiatives and individual philanthropists to modernise, streamline and strengthen its delivery of vaccines to children in the world’s poorest countries over the next 15 years. Meanwhile, Médecins sans Frontières […] Continue reading -> COVID-19 Is Exacerbating Antibiotic Use – And Antimicrobial Resistance Is Rising Fast, WHO Warns 02/06/2020 Svĕt Lustig Vijay As the COVID-19 pandemic spawns increased antibiotic use all over the world, more drug-resistant microbes are bound to bite us back , said Dr. Tedros at a WHO press conference on Monday. The repercussions on disease treatment and deaths will be severe, given that the world is running out of effective ways to treat antimicrobial […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> Posts navigation Older postsNewer posts
United Kingdom Pauses Massive Hydroxychloroquine Trial After Finding “No Benefit” For COVID-19 Patients; The Lancet Retracts Hydroxychloroquine Paper 04/06/2020 Grace Ren In a series of flip-flops on Friday, the United Kingdom suspended the enrollment of new patients into the hydroxychloroquine arm of its massive RECOVERY trial, one of the largest randomised COVID-19 clinical trials in the world, after preliminary data showed “no benefit” for COVID-19 patients receiving the drug. The suspension of the trial came just […] Continue reading -> Gavi, The Vaccine Alliance Receives Big Private Industry Funding Commitments – Ahead Of Pledging Summit 03/06/2020 Elaine Ruth Fletcher & Grace Ren A day ahead of a major pledging event, Gavi-the Vaccine Alliance has received some US $70 million in pledges from a broad range of corporations, foundations, initiatives and individual philanthropists to modernise, streamline and strengthen its delivery of vaccines to children in the world’s poorest countries over the next 15 years. Meanwhile, Médecins sans Frontières […] Continue reading -> COVID-19 Is Exacerbating Antibiotic Use – And Antimicrobial Resistance Is Rising Fast, WHO Warns 02/06/2020 Svĕt Lustig Vijay As the COVID-19 pandemic spawns increased antibiotic use all over the world, more drug-resistant microbes are bound to bite us back , said Dr. Tedros at a WHO press conference on Monday. The repercussions on disease treatment and deaths will be severe, given that the world is running out of effective ways to treat antimicrobial […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> Posts navigation Older postsNewer posts
Gavi, The Vaccine Alliance Receives Big Private Industry Funding Commitments – Ahead Of Pledging Summit 03/06/2020 Elaine Ruth Fletcher & Grace Ren A day ahead of a major pledging event, Gavi-the Vaccine Alliance has received some US $70 million in pledges from a broad range of corporations, foundations, initiatives and individual philanthropists to modernise, streamline and strengthen its delivery of vaccines to children in the world’s poorest countries over the next 15 years. Meanwhile, Médecins sans Frontières […] Continue reading -> COVID-19 Is Exacerbating Antibiotic Use – And Antimicrobial Resistance Is Rising Fast, WHO Warns 02/06/2020 Svĕt Lustig Vijay As the COVID-19 pandemic spawns increased antibiotic use all over the world, more drug-resistant microbes are bound to bite us back , said Dr. Tedros at a WHO press conference on Monday. The repercussions on disease treatment and deaths will be severe, given that the world is running out of effective ways to treat antimicrobial […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Is Exacerbating Antibiotic Use – And Antimicrobial Resistance Is Rising Fast, WHO Warns 02/06/2020 Svĕt Lustig Vijay As the COVID-19 pandemic spawns increased antibiotic use all over the world, more drug-resistant microbes are bound to bite us back , said Dr. Tedros at a WHO press conference on Monday. The repercussions on disease treatment and deaths will be severe, given that the world is running out of effective ways to treat antimicrobial […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> Posts navigation Older postsNewer posts
Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> Posts navigation Older postsNewer posts
France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> Posts navigation Older postsNewer posts
Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> Posts navigation Older postsNewer posts
Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> Posts navigation Older postsNewer posts
GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> Posts navigation Older postsNewer posts